articleAnnals of the Rheumatic DiseasesJan 28, 2005BRONZE OA

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

Friedrich-Alexander-Universität Erlangen-Nürnberg · University of Utah · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

715
total citations
FWCI
31.26
Percentile
100%
References
43
Citations per year

Authors

9

Topics & keywords

Keywords
  • Medicine
  • Infliximab
  • Placebo
  • Psoriasis
  • Psoriatic arthritis
  • Internal medicine
  • Dactylitis
  • Enthesopathy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.